These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29180385)

  • 21. [Pulmonary Embolism Despite Rivaroxaban in an Obese Patient].
    Schuh T; Stöllberger C
    Dtsch Med Wochenschr; 2017 Oct; 142(20):1548-1551. PubMed ID: 29017215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous Thromboembolism and Sarcoidosis: A Case Report.
    Arab TM; Decter ER; Ullah T; Thurm CA
    Am J Case Rep; 2019 Nov; 20():1745-1749. PubMed ID: 31765366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience.
    Arachchillage D; Reynolds R; Devey T; Maclean R; Kitchen S; van Veen JJ
    Thromb Res; 2016 Nov; 147():32-35. PubMed ID: 27669125
    [No Abstract]   [Full Text] [Related]  

  • 24. Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the HoT-PE Trial.
    Barco S; Lankeit M; Binder H; Schellong S; Christ M; Beyer-Westendorf J; Duerschmied D; Bauersachs R; Empen K; Held M; Schwaiblmair M; Fonseca C; Jiménez D; Becattini C; Quitzau K; Konstantinides S
    Thromb Haemost; 2016 Jul; 116(1):191-7. PubMed ID: 27010343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and Safety of Rivaroxaban in Patients with Venous Thromboembolism and Active Malignancy: A Single-Center Registry.
    Bott-Kitslaar DM; Saadiq RA; McBane RD; Loprinzi CL; Ashrani AA; Ransone TR; Wolfgram AA; Berentsen MM; Wysokinski WE
    Am J Med; 2016 Jun; 129(6):615-9. PubMed ID: 26797081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of rivaroxaban starter packs on emergency department throughput.
    Ayers GT; D'Amico PhD F; Farrah RM; Klatt PM; Baumgartner MA
    Am J Emerg Med; 2018 Sep; 36(9):1698-1699. PubMed ID: 29429797
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of low-dose rivaroxaban in an 88-year-old female with pulmonary embolism: A case report.
    Zhou H; Wei Q; Wu H; Tang M; Yang S; Liu Y; Qin L
    Medicine (Baltimore); 2019 May; 98(20):e15705. PubMed ID: 31096518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of pulmonary embolism.
    Décousus H; Mismetti P; Couturaud F; Ageno W; Bauersachs R
    Presse Med; 2015 Dec; 44(12 Pt 2):e393-9. PubMed ID: 26547678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The EINSTEIN CHOICE study].
    Agnelli G; Becattini C; Giustozzi M; Imberti D; Benedetti R; Fontana M
    G Ital Cardiol (Rome); 2017 Sep; 18(9):613-617. PubMed ID: 28845870
    [No Abstract]   [Full Text] [Related]  

  • 30. Direct Oral Anticoagulants: Overcoming the Challenges of Managing Venous Thromboembolism in Children.
    Male C; Monagle P; Albisetti M; Brandão LR; Young G
    J Pediatr; 2022 Jan; 240():14-23. PubMed ID: 34687696
    [No Abstract]   [Full Text] [Related]  

  • 31. Rivaroxaban for treatment of venous thromboembolism in older adults.
    Mitchell AP; Conway SE
    Consult Pharm; 2014 Sep; 29(9):627-30. PubMed ID: 25203412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of rivaroxaban in real-life treatment of venous thromboembolism: results of the TEV Survey, an Italian epidemiological study].
    Pesavento R; Iori I;
    G Ital Cardiol (Rome); 2017 Mar; 18(3):239-246. PubMed ID: 28398382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing Length of Stay Between Patients Taking Rivaroxaban and Conventional Anticoagulants for Treatment of Venous Thromboembolism.
    Desai A; Desai A; Calixte R; Aparnath M; Hindenburg A; Salzman S; Mathew JP
    Lung; 2016 Aug; 194(4):605-11. PubMed ID: 27192990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rivaroxaban for Treatment of Pulmonary Embolism While Receiving Electroconvulsive Therapy.
    Shao E; Moore R; Linnane J
    J ECT; 2017 Sep; 33(3):e25-e26. PubMed ID: 28198719
    [No Abstract]   [Full Text] [Related]  

  • 35. Venous thromboembolism therapy with rivaroxaban in daily-care patients: Results from the Dresden NOAC registry.
    Keller L; Marten S; Hecker J; Sahin K; Tittl L; Beyer-Westendorf J
    Int J Cardiol; 2018 Apr; 257():276-282. PubMed ID: 29506708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rivaroxaban versus standard anticoagulation for symptomatic venous thromboembolism (REMOTEV observational study): Analysis of 6-month outcomes.
    Gaertner S; Cordeanu EM; Nouri S; Faller AM; Frantz AS; Mirea C; Bilbault P; Ohlmann P; Le Ray I; Stephan D
    Int J Cardiol; 2017 Jan; 226():103-109. PubMed ID: 27806307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns and Predictors of Use of Anticoagulants for the Treatment of Venous Thromboembolism Following Approval of Rivaroxaban.
    Dault R; Vanasse A; Blais L; Perreault S; Farand P; Le Templier G; Beauchesne MF
    Clin Appl Thromb Hemost; 2016 Nov; 22(8):765-771. PubMed ID: 26467323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute cytomegalovirus infection associated with pulmonary embolism treated successfully with rivaroxaban: case report.
    de Almeida CMG; Maluf FC; Maluf FC; Gaburo N; Saraceni AF; de Almeida-Neto C
    J Thromb Thrombolysis; 2019 Jan; 47(1):162-164. PubMed ID: 30353451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rivaroxaban in the treatment of venous thromboembolism and the prevention of recurrences: a practical approach.
    Arcelus JI; Domènech P; Fernández-Capitan Mdel C; Guijarro R; Jiménez D; Jiménez S; Lozano FS; Monreal M; Nieto JA; Páramo JA
    Clin Appl Thromb Hemost; 2015 May; 21(4):297-308. PubMed ID: 25504999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low molecular weight heparin versus rivaroxaban in the treatment of venous thromboembolism in gastrointestinal malignancies.
    Choe HK; De Sancho MT; Kim SS; Dai T; Shah MA
    Blood Coagul Fibrinolysis; 2018 Mar; 29(2):227-230. PubMed ID: 29389673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.